Biofrontera AG (B8F):企業の財務・戦略的SWOT分析

◆英語タイトル:Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH22166FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Biofrontera AG (B8F) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and markets dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED, Xepi, Aktipak and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic keratosis. Biofrontera’s BF-RhodoLED is a lamp used for photodynamic therapy with LEDs emitting red light. Belixos is a cosmetic product,indicated for regenerative care of reddened and inflamed skin. Its Belixos line of products include Belixos creme, Belixos liquid, Belixos gel, and Belixos protect. The company distributes its products through pharmaceutical wholesalers and licensing partners. Biofrontera is headquartered in Leverkusen, Germany.

Biofrontera AG Key Recent Developments

Jul 23,2020: Supervisory Board of Biofrontera renews management board appointment
May 19,2020: Biofrontera : Biofrontera reports Q1 2020 financial results
May 13,2020: Biofrontera AG: Biofrontera dismisses case against Dusa Pharmaceuticals in California state court
Apr 20,2020: Biofrontera reports full year 2019 financial results
Apr 17,2020: Biofrontera reports preliminary unaudited sales revenue for the first three months of 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Biofrontera AG – Key Facts
Biofrontera AG – Key Employees
Biofrontera AG – Key Employee Biographies
Biofrontera AG – Major Products and Services
Biofrontera AG – History
Biofrontera AG – Company Statement
Biofrontera AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Biofrontera AG – Business Description
Geographical Segment: Europe
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Other regions
Performance
Geographical Segment: The US
Performance
R&D Overview
Biofrontera AG – SWOT Analysis
SWOT Analysis – Overview
Biofrontera AG – Strengths
Biofrontera AG – Weaknesses
Biofrontera AG – Opportunities
Biofrontera AG – Threats
Biofrontera AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Biofrontera AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 23, 2020: Supervisory Board of Biofrontera renews management board appointment
May 19, 2020: Biofrontera : Biofrontera reports Q1 2020 financial results
May 13, 2020: Biofrontera AG: Biofrontera dismisses case against Dusa Pharmaceuticals in California state court
Apr 20, 2020: Biofrontera reports full year 2019 financial results
Apr 17, 2020: Biofrontera reports preliminary unaudited sales revenue for the first three months of 2020
Jan 31, 2020: Organizational restructuring of Biofrontera and resignation of chief commercial officer Christoph Dünwald
Jan 06, 2020: Biofrontera strengthens commercial focus with reorganization of its US business
Dec 13, 2019: Biofrontera: Christopher Pearson appointed new Chief Commercial Officer at US subsidiary Biofrontera
Nov 19, 2019: Biofrontera reports third quarter 2019 financial results and revises guidance
Aug 27, 2019: Biofrontera shows robust growth during first six months of 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Biofrontera AG, Key Facts
Biofrontera AG, Key Employees
Biofrontera AG, Key Employee Biographies
Biofrontera AG, Major Products and Services
Biofrontera AG, History
Biofrontera AG, Subsidiaries
Biofrontera AG, Key Competitors
Biofrontera AG, Ratios based on current share price
Biofrontera AG, Annual Ratios
Biofrontera AG, Annual Ratios (Cont...1)
Biofrontera AG, Interim Ratios
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Biofrontera AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Biofrontera AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Biofrontera AG (B8F):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Empresaria Group plc (EMR):企業の財務・戦略的SWOT分析
    Empresaria Group plc (EMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • LG Life Science LTD (068870)-製薬・医療分野:企業M&A・提携分析
    Summary LG Life Science LTD (LGLS) is a global life science company that offers development, production and marketing of pharmaceutical products. The company provides pipeline of antibiotic, Factive and other drug candidates. Its products include vaccines, anti-infective, chemicals, veterinary medic …
  • Conn’S, Inc.:企業の戦略・SWOT・財務分析
    Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Europa Oil & Gas (Holdings) plc (EOG):企業の財務・戦略的SWOT分析
    Summary Europa Oil & Gas (Holdings) Plc (Europa Oil) is an oil and gas company that offers exploration and development services. The company's services include production and development of conventional and unconventional hydrocarbon assets. It operates its assets in East Midlands basin, Aquitain ba …
  • Curtiss-Wright Corp (CW):電力:M&Aディール及び事業提携情報
    Summary Curtiss-Wright Corp (Curtiss-Wright) is a manufacturing and service company. It designs, manufactures, and overhauls precision components and provides highly engineered critical function products. The company also provides support services for critical applications. Curtiss-Wright serves cus …
  • RRB Energy Ltd:企業の戦略的SWOT分析
    RRB Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Helijet International Inc.:企業の戦略・SWOT・財務分析
    Helijet International Inc. - Strategy, SWOT and Corporate Finance Report Summary Helijet International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Marshall Aerospace and Defence Group:企業の戦略・SWOT・財務情報
    Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report Summary Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Exandal Corp.:企業の戦略・SWOT・財務情報
    Exandal Corp. - Strategy, SWOT and Corporate Finance Report Summary Exandal Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ra Pharmaceuticals Inc (RARX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • Caladrius Biosciences Inc (CLBS):企業の財務・戦略的SWOT分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company. The company develops cellular therapies for the treatment cardiovascular indications and autoimmune diseases. The company's products pipeline includes CLBS03 is an autologous ex vivo p …
  • Reliable Ventures India Limited:戦略・SWOT・企業財務分析
    Reliable Ventures India Limited - Strategy, SWOT and Corporate Finance Report Summary Reliable Ventures India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Advanced Micro Devices Inc (AMD):企業の財務・戦略的SWOT分析
    Advanced Micro Devices Inc (AMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hitachi Zosen Corporation (7004):企業の財務・戦略的SWOT分析
    Hitachi Zosen Corporation (7004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Murree Brewery Co. Ltd.:戦略・SWOT・企業財務分析
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Biocare Medical LLC-医療機器分野:企業M&A・提携分析
    Summary Biocare Medical LLC (Biocare) develops and supplies automated immunohistochemistry instrumentation and reagents. The company offers androgen receptor, amyloid A, estrogen receptor, ERG, factor xlla and folate receptor alpha IHC assay kit, among others. It offers on-site training, technical s …
  • FieldPoint Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    FieldPoint Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary FieldPoint Petroleum Corp (FieldPoint) is an oil and gas company that acquires, operates and develops oil and gas properties. The company’s acquisition includes leasehold and working intere …
  • Serco Group plc (SRP):企業の財務・戦略的SWOT分析
    Serco Group plc (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • QT Holdings Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary QT Holdings Corp, d.b.a Quad Technologies, a subsidiary of Bio Techne Corp, is a life sciences company that strives to develop bioprocessing reagents for cell-based therapeutics. The company offers QuickGel, a biocompatible dissolvable polymer technology, for cell separation and activation. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆